Depression is today’s most prevalent mental health disorder and the leading cause of disability worldwide. However, the pain and burdens of depression are not limited to those diagnosed.
Impact of the Depression Epidemic: Family & Community
atai Life Sciences announces the launch of PsyProtix, to develop a precision psychiatry approach for Treatment-Resistant Depression (TRD)
atai Life Sciences (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced…
JOIN THE ATAI #INSIGHTNETWORK